RCN chief ‘absolutely committed’ to improving pay for all nurses
The RCN chief has renewed her commitment to improving pay for all nursing staff across the UK in a New Year message to the profession.
Related Articles
Embracing Change in the Face of Aging and Breast Cancer
I’ve learned to embrace the changing nature of my body as I age, accepting the challenges and finding gratitude in each day.
FDA Accepts New Drug Application For Taletrectinib in ROS1+ NSCLC
The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell lung cancer.
Adherence to Evidence‐Based Guidelines and Implications When Designing Electronic Documentation for Urinary Catheters
Aim The aim of this study was to investigate the point prevalence and the rate of adherence to evidence-based guidelines for patients who had indwelling…
CAR T-Cell Therapy Yescarta Continues to Demonstrate Durable Responses in Follicular Lymphoma
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma.
UK cut funds to ‘red list’ countries while ‘heavily recruiting’ their nurses
The government has been accused of cutting crucial health spending aid to countries with severe nursing shortages, while ‘heavily’ recruiting
Emotional S&M Nurses – Joni Watson
Sadomasochism, or S&M, has its place in nursing as it does within any profession. I’m not talking about physical, sexual S&M. I mean emotional S&M.…
Over a third of practice nurses spend one hour or less on training a week
More than a third (36%) of general practice nursing staff say they spend one hour or less per week on training and development opportunities
Older adults undergoing major elective surgery experience significant emotional distress: insights into the surgical patient experience
Commentary on : Kata A, Dillon EC, Christina Keny RN, et a l.‘There’s So Much That They’re Enduring’: Experiences of Older Adults Undergoing Major Elective…
FDA Reviews NDA for Dordaviprone in Recurrent H3 K27M-Mutant Diffuse Glioma
Chimerix submitted a new drug application to the FDA seeking accelerated approval for dordaviprone to treat patients with recurrent H3 K27M-mutant diffuse glioma.
Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer | JCO Clinical Cancer Informatics
PURPOSEModeling passively collected smartphone sensor data (called digital phenotyping) has the potential to detect distress among family caregivers and patients with advanced cancer and could…
